Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests

Annals of Saudi Medicine

Volumn 30, Issue 3, 2010, Pages 193-197

  Gao, Xiaofang ^a,b   Chen, Liangan ^a,b   Hu, Guangrong ^a,b   Mei, Haiyu ^a,b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Chinese People's Liberation Army No 150 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA 1,3 GLUCAN; CASPOFUNGIN; CORTICOSTEROID; GALACTOMANNAN; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; VORICONAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC TEST; DISEASE EXACERBATION; FEMALE; HUMAN; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEROLOGY;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; AGED; ANTIGENS, FUNGAL; BETA-GLUCANS; FEMALE; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 77952317725     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.62828     Document Type: Article

References (25)

1. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-1821.
2. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;6:781-803.
3. Bulpa PA, Dive AM, Garrino MG, Delos MA, Gonzalez MR, Evrard PA, et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: Benefits of intensive care? Intensive Care Med 2001;27:59-67.
4. Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Report of eight cases and review. Clin Infect Dis 1998;26:1473-1475
5. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: Systematic review of the literature. Clin Infect Dis 2001;32:358-366
6. Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, et al. Invasive aspergillosis: Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000;79:250-260
7. Rodrigues J, Niederman MS, Fein AM, Pai PB. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 1992;93:29-34.
8. Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, Pelaez T, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome. Clin Microbiol Infect 2009 Nov 10 (Epub ahead of print).
9. Guinea J, Jensen J, Pelaez T, Gijon P, Alonso R, Rivera M, et al. Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol 2008;46:575-579
10. Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003;349:2366-2367
11. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276
12. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946
13. Pittet D, Huguenin T, Dharan S, Sztajzel-Boissard J, Ducel G, Thorens JB, et al. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:541-544
14. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007;30:782-800.
15. Lai CC, Hsu HL, Lee LN, Hsueh PR. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis. J Microbiol Immunol Infect 2007;40:148-153
16. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1→3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005;43:5957-5962
17. Kozinn PJ, Taschdjian CL, Goldberg PK, Protzmann WP, MacKenzie DW, Remington JS, et al. Efficiency of serologic tests in the diagnosis of systemic candidiasis. Am J Clin Pathol 1978;70:893-898
18. Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004;4:349-357
19. Caillot D, Mannone L, Cuisenier B, Couaillier JF. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin Microbiol Infect 2001;7:54-61.
20. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-1121 (Pubitemid 43726892)
21. Ng TT, Robson GD, Denning DW. Hydrocortisone- enhanced growth of Aspergillus spp.: Implications for pathogenesis. Microbiology 1994;140:2475-2479
22. Leav BA, Fanburg B, Hadley S. Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone. N Engl J Med 2000;343:586.
23. Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 2006;10:R31.
24. Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004;4:349-357
25. Ishizuka Y, Tsukada H, Gejyo F. Interference of (1 --→ 3)-beta-D-glucan administration in the measurement of plasma (1 --→ 3)-beta-D-glucan. Intern Med 2004;43:97-101.